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Endocytosis and the development of cell polarity in yeast require
a dynamic F-actin cytoskeleton
Kathryn R. Ayscough
Studies using drugs that cause the disassembly of
filamentous actin (F-actin) have demonstrated the
importance of an intact actin cytoskeleton for
polarised secretion by yeast cells [1,2]. To address the
level of dynamic turnover needed for such processes,
however, drugs or mutants that confer stabilising
properties on F-actin are needed. Jasplakinolide is the
only readily available drug that stabilises F-actin
structures both in vivo and in vitro [3–6]. Yeast strains
have been generated in which two of the ABC
multidrug resistance transporter genes have been
deleted, rendering normally jasplakinolide-resistant
yeast cells sensitive to its effects. Treatment of these
cells with jasplakinolide caused rapid and dramatic
effects on the actin cytoskeleton, resulting in the
accumulation of single large actin structures in
cells. These structures, however, still contained
components that are normally associated with
cortical actin patches. A dynamic actin cytoskeleton
was found to be critical for the generation of cell
polarity and endocytosis.
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Results and discussion
Previous work demonstrated that relatively high concen-
trations of jasplakinolide do not inhibit growth of wild-
type yeast cells, nor does the drug affect actin structures,
as determined by rhodamine–phalloidin staining [1]. Here,
the effects of jasplakinolide were analysed in a Saccha-
romyces cerevisiae strain in which two multidrug resistance
ABC-transporter genes (PDR5 and SNQ2) were deleted
from the genome. While this strain is sensitive to a range
of drugs, it is morphologically the same as wild-type yeast
cells and rhodamine–phalloidin staining indicates that its
actin cytoskeleton is organised appropriately (K.R.A.,
unpublished data). Sensitivity to jasplakinolide was assessed
as detailed in the Supplementary material. The lowest
concentration of jasplakinolide at which effects on growth
were observed (10 µM) was then used to analyse the effects
of the drug on the actin structures within cells. 
Using rhodamine–phalloidin to stain F-actin structures, a
rapid and dramatic alteration in the actin cytoskeleton of
jasplakinolide-treated cells was observed. Rather than
many small cortical patches, a single large clump of actin
was present (Figure 1a,b). The staining obtained with
rhodamine–phalloidin was considerably weaker than is
Figure 1
Effect of jasplakinolide on actin. (a) Untreated wild-type cells showed
both cytoplasmic cables and cortical small bright spots when fixed and
stained with rhodamine–phalloidin. (b) A 30 min treatment with 10 µM
jasplakinolide caused a redistribution of actin to a single, large, but
fainter, clump in cells. (c) Washing of cells before fixation and staining
to remove jasplakinolide revealed a single large clump of actin, now
brightly stained. (d–g) Live cells expressing Abp1–GFP were also used
to visualise the localisation of cortical actin. (d) Untreated cells showing
small punctate cortical patches. (e) Cells after 10 min in the presence
of 10 µM jasplakinolide. (f) Cells were then incubated in the presence
of 50 µM LAT-A for a further 2 h. (g) The eight figures are successive
images taken at 20 sec intervals from a series of images recorded
between 5–10 min after addition of 10 µM jasplakinolide. The arrow
denotes a point where patches were observed to coalesce into a single
large clump of actin. The arrowhead indicates a particular patch that
became a part of this clump. Scale bars represent (c, f) 10 µm; (g) 5 µm.





normally seen for F-actin structures in yeast, however, and
actin cable structures were not observed at all. This sup-
ports previous in vitro reports which indicate competitive
binding of jasplakinolide and rhodamine–phalloidin [5].
Treating cells with jasplakinolide for 10 minutes, then
washing the cells, releasing into fresh medium and imme-
diately taking a sample for rhodamine–phalloidin staining
then revealed a single, but bright aggregate of F-actin
staining and actin cables could be visualised, demonstrat-
ing release of jasplakinolide and renewed access for rho-
damine–phalloidin (Figure 1c). This competition in
F-actin binding suggests a site for jasplakinolide binding
overlapping that for phalloidin, which has been mapped to
the crux of three actin monomers within the filament [7,8]. 
To assess whether the actin clumps represented dynamic
or static F-actin structures within the cell, another drug,
latrunculin-A (LAT-A), was used. Previous studies
demonstrated that LAT-A is a rapid and reversible
inhibitor of actin polymerisation that acts by association
with the actin monomer, thus preventing its reincorpora-
tion into filaments [1,9]. If actin in jasplakinolide-induced
structures is dynamic, the monomer will be released and
could be sequestered by LAT-A, leading to the steady
dispersal of the aggregates. If, however, jasplakinolide sta-
bilises the structures such that the actin is not dynamic,
then the aggregates will persist in the presence of LAT-A.
The jasplakinolide-sensitive yeast were assessed for
LAT-A sensitivity and 10 µM LAT-A was found to cause
> 98% of actin structures to disassemble after 15 minutes
incubation, a similar degree of effect compared with
incubation of wild-type strains with 200 µM LAT-A (data
not shown) [1].
Approaches, using both fixed and live cells, were used to
study the effects of jasplakinolide and LAT-A treatment.
For live-cell studies, yeast were transformed with a
plasmid expressing green fluorescent protein (GFP)-
tagged Abp1p. Abp1p is a protein that binds directly to
actin and colocalises with cortical actin patches [10].
Similar results were obtained with both live and fixed
cells but only those obtained with the Abp1–GFP are
reported here. To investigate whether F-actin clumps
were dynamic, Abp1–GFP-expressing cells were incu-
bated with jasplakinolide for 10 minutes when over 90%
of actin was observed to be reorganised from multiple
cortical patches (Figure 1d) into one or two clumps in cells
(Figure 1e). LAT-A was then added at various concentra-
tions either equal to (10 µM), or up to 5 times, that of
jasplakinolide. The effects on the actin clumps over time
points up to 8 hours were monitored. Over this time
course, no dispersal of the aggregates was observed at any
concentration of LAT-A, indicating that the aggregates
are extremely stable structures and suggesting that
monomeric actin is not released and made available for
LAT-A binding (Figure 1f).
Possible mechanisms for formation of actin clumps could
be that either the monomer is released from existing
patches and then stably incorporated into an increasingly
large jasplakinolide-stabilised clump, or that existing
patches can coalesce and fuse to form large clumps. Time-
lapse images taken at 20 second intervals demonstrated
the movement and fusion of existing clumps rather than
one patch growing as other patches depolymerise with
their actin being reincorporated into the single clump (see
Figure 1g and the video in Supplementary material). Fur-
thermore, the continued movement of cortical patches as
they reorganise into the jasplakinolide-induced clump
supports the idea that actin dynamics are not required for
actin-patch movement in yeast [11,12].
To ascertain whether the actin in these large clumps was
structurally affected or similar to that in untreated cells,
we performed double-labelling immunofluorescence with
antibodies against actin and several components that nor-
mally associate with cortical F-actin patches: Arp2, Abp1
and cofilin [10,13,14], and Sac6p which associates with
both patch and cable structures [10]. Following jasplakino-
lide treatment, all four components were seen to colocalise
with the large clumps of F-actin, providing convincing evi-
dence that the actin within the patches is filamentous
rather than monomeric (Figure 2). Furthermore, the large
actin structures were also unlikely to represent aberrantly
polymerised F-actin aggregates or precipitates as several
protein-binding sites were preserved. Furthermore, when
using antibodies to visualise actin rather than rho-
damine–phalloidin, actin cables in cells in the presence of
jasplakinolide were seen. Sac6p colocalised with actin in
these structures, demonstrating that both actin patch and
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Figure 2
The actin clumps induced by jasplakinolide contain proteins normally
associated with cortical actin patches. Cells in exponential growth
phase were treated for 30 min with 10 µM jasplakinolide, then fixed
and processed for immunofluorescence as described in the
Supplementary material. Double labelling was performed using
antibodies against yeast actin and (a) Arp2p, (b) Abp1p, (c) cofilin
(Cof1p) and (d) Sac6p. The scale bar represents 10 µm. 
(a)
(b)
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actin cable binding sites are maintained and provides
further evidence that jasplakinolide stabilisation of actin
does not cause gross perturbation of actin subdomain
organisation within filaments. 
In studies of motile mammalian cells, at early time points
after drug addition, F-actin stabilisation effects similar to
those observed here have been reported but, at later times,
a dramatic increase in F-actin levels is observed, presum-
ably because of mobilisation of actin from sequestered
monomer pools and its incorporation into filaments [4].
Thus, with prolonged incubation, it is difficult to deter-
mine whether the effects observed are due to actin stabili-
sation or because cells contain more F-actin. In yeast,
nearly all actin is in the F-actin form and there is very
little ‘reserve’ of G-actin available for such bursts of poly-
merisation (G-actin has been measured as about 0.015 ng/µg
of total cell protein with total actin being measured as
about 1.5 ng/µg total protein — thus G-actin represents
only about 1% of yeast cell actin [15,16]). An increase in
level of F-actin is therefore unlikely on addition of jas-
plakinolide to yeast, and changes observed will be due to
an increase in F-actin stabilisation. 
Having established that jasplakinolide abrogates F-actin
dynamics in yeast, mechanisms requiring an intact actin
cytoskeleton were investigated to assess whether they
also require the actin to be dynamic. It was determined
whether, in the presence of jasplakinolide, a population of
unbudded cells could form a bud and whether they could
localise the polarity marker Cdc42p. In yeast, Cdc42p
localises as a single patch at the presumptive site of bud
formation and to the tip of growing buds [17] and is
required for the generation of cell polarity [18]. In the
untreated cells, budding was observed after 2 hours and
Cdc42p became localised to a patch at the bud site and to
the tip of the growing bud (Figure 3a,b). At 4 hours, over
75% of cells showed polarised staining of Cdc42p. In the
presence of jasplakinolide cells did not bud, nor did Cdc42p
become localised (Figure 3c,d), indicating the importance
for cellular F-actin to be dynamic for the establishment
of cell polarity. 
Actin is also critical for endocytosis in yeast, and treat-
ment of cells with LAT-A, which depolymerises the actin
cytoskeleton, completely blocks uptake of the fluid-phase
marker lucifer yellow (LY) [1]. In the absence of jasplaki-
nolide, uptake of LY into vacuoles could be clearly seen
(Figure 4a). In jasplakinolide-treated cells, uptake was
severely abrogated, though very low levels of fluorescence
in the vacuoles could still be observed (Figure 4b). A par-
ticularly interesting observation was that, in jasplakino-
lide-treated cells, rather than LY staining being observed
uniformly over the cell surface as observed in studies
when actin is disrupted in yeast cells [11,12,19,20], there
appeared to be discrete spots of staining at the cell cortex,
suggesting that endocytosis is stalled at a specific stage in
the uptake process. This previously unreported observa-
tion of bright punctate staining at the cortex suggests a
hitherto uncharacterised requirement for F-actin at a spe-
cific stage in the endocytic process, and future studies will
aim to characterise in more detail the stage at which endo-
cytosis is blocked following F-actin stabilisation. A similar
‘single actin-clump’ phenotype is observed in cells in
which genes for the actin-regulating kinases Ark1p and
Prk1p are deleted [21]. It will be of interest to ascertain
whether these kinases are directly involved in regulation
of actin dynamics and have effects on endocytosis similar
to those observed following jasplakinolide treatment.
The studies presented here demonstrate that the actin-
stabilising drug jasplakinolide can dramatically affect the
actin cytoskeleton in S. cerevisiae. The structures formed
appeared to be structurally similar to normal F-actin struc-
tures in yeast but were no longer dynamic. Use of jasplaki-
nolide has made it possible to address the question of the
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Figure 3
Dynamic F-actin is required for the generation
of cell polarity. An unbudded population of
cells was incubated in the presence or
absence of 10 µM jasplakinolide (J) and
samples taken hourly for 4 h following release.
Immunolocalisation of Cdc42p in cells exiting
stationary phase in the (a,b) absence or
(c,d) presence of 10 µM jasplakinolide.
The images shown were recorded after
(a,c) 2 h or (b,d) 4 h following release into
fresh medium. Note the absence of bud
formation or polarised localisation of Cdc42p
in the presence of the drug. The scale bar
represents 10 µm. (e) Kinetics of Cdc42p
localisation in cells in the absence or
presence of jasplakinolide.































requirement for actin in yeast to be dynamic and demon-
strate that this property is essential for the fundamental
processes of polarity establishment and endocytosis, but is
not necessary for movement of cortical actin. 
Supplementary material
Additional methodological detail, a movie showing cells expressing
Abp1–GFP in the presence and absence of jasplakinolide, and a 
figure showing the assay used to determine the sensitivity of strains to jas-
plakinolide is available at http://current-biology.com/supmat/supmatin.htm. 
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Figure 4
Fluid-phase endocytosis requires the presence of dynamic F-actin.
Fluid-phase endocytosis was assessed by uptake of LY (see
Supplementary material). Cells were either (a) untreated or
(b) incubated in the presence of 10 µM jasplakinolide for 10 min prior
to addition of LY and then throughout the 2 h incubation with the stain.
To allow comparison of uptake, the time of exposure for image
recording was the same in each case. The scale bar represents 10 µm.
(a) (b)
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